Minerva Neurosciences, Inc.
NERV
$1.67
-$0.055-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 11.54M | 84.80K | 3.86M | 4.17M | 12.04M |
| Gross Profit | -11.54M | -84.80K | -3.86M | -4.17M | -12.04M |
| SG&A Expenses | 2.54M | 2.48M | 2.42M | 2.51M | 2.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.52M | 4.37M | 6.28M | 6.68M | 7.17M |
| Operating Income | -4.52M | -4.37M | -6.28M | -6.68M | -7.17M |
| Income Before Tax | -4.27M | 22.51M | -8.23M | -8.57M | -9.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.27M | 22.51M | -8.23M | -8.57M | -9.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.27M | 22.51M | -8.23M | -8.57M | -9.02M |
| EBIT | -4.52M | -4.37M | -6.28M | -6.68M | -7.17M |
| EBITDA | -4.52M | -4.37M | -6.28M | -6.68M | -7.17M |
| EPS Basic | -0.56 | 2.97 | -1.09 | -1.13 | -1.19 |
| Normalized Basic EPS | -0.35 | 1.86 | -0.68 | -0.71 | -0.75 |
| EPS Diluted | -0.56 | 2.97 | -1.09 | -1.13 | -1.19 |
| Normalized Diluted EPS | -0.35 | 1.86 | -0.68 | -0.71 | -0.75 |
| Average Basic Shares Outstanding | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M |
| Average Diluted Shares Outstanding | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |